… Genome-wide association studies (GWAS) provide biological insights into disease onset
and progression and have potential to produce clinically useful biomarkers. A growing body of …

… architecture of SCZ, multiple genome-wide association studies (GWASs) have … of psychiatric
disorders were collected and evaluated. The age at first manifestation of positive symptoms …

… Recent meta-analyses combining direct genome-wide association studies (GWAS) with
those of family history (GWAX) have indicated very low SNP heritability of Alzheimer’s disease (…

… The AD-PRS was generated based on genetic variants from the remarkable AD genome-wide
association study provided by the International Genomics of Alzheimer’s Project. The …

… ranging from 40 to 88% 13,14,15,16,17,18,19,20 , and a number of genome-wide …
genome-wide association studies (GWASs), especially through the collective effort of the Psychiatric …

… AD is a hereditary disease. The heritability is estimated to be between 60% and 80% (4).
Recent genome-wide association studies (GWASs) conducted by Schwartzentruber et al. (5) …

… accompanied by psychiatric comorbidities. Recent genome-wide association studies (GWAS) …
A shared genetic component between tinnitus and psychiatric conditions remains elusive. …

… Here we performed a genome-wide association study of … We discovered genome-wide
significant loci unique to each … and psychiatric public health consequences that require further …

… deficits in psychosis. However, few studies have investigated the genetic basis of verbal
memory in a neurodevelopmental context, and most genome-wide association studies (GWASs) …

… Individuals with a record of neurological disorders or psychiatric illnesses were excluded …
Patients with neurodegenerative disorder such as Alzheimer's disease exhibit reduced serum …